Yohji Sakurai

This inventor holds 13 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1996-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yohji Sakurai. Retrieved from https://idiyas.com/inventor/yohji-sakurai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 9)

% Patents Active = 38.5

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 8.5

ph-index = 3

Forward Citations = 23(Granted Patents)

Location History:

Itano-gun, JP (1999)
Tokushima, JP (1996 - 2018)
Osaka, JP (2015 - 2020)

Company Filing History:

13 out of 846

Otsuka Pharmaceutical Company, Limited

patents

Years Active: 1996-2020

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10626095 - Cyanotriazole compounds (2020-04-21),

2. 10000450 - N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2018-06-19),

3. 9611214 - N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2017-04-04),

4. 9539252 - Piperazine-substituted benzothiophene derivatives as antipsychotic agents (2017-01-10),

5. 9260420 - Piperazine-substituted benzothiophene derivatives as antipsychotic agents (2016-02-16),

6. 9206173 - Heterocyclic compounds for the treatment of stress-related conditions (2015-12-08),

7. 8815871 - N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2014-08-26),

8. 8598162 - Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders (2013-12-03),

9. 8420623 - N, N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2013-04-16),

10. 8084442 - N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2011-12-27),

11. 8071600 - Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders (2011-12-06),

12. 5942641 - Fluorenone derivatives, process for preparing the same and central or (1999-08-24),

13. 5550292 - Benzylamine derivatives (1996-08-27),

Title: The Innovative Mind of Yohji Sakurai: Patents and Contributions to Pharmaceutical Advancements

Introduction: Yohji Sakurai, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the field of pharmaceuticals through his innovative patents. With a total of 13 patents to his name, his work focuses primarily on compounds that promote health and well-being.

Latest Patents: Among his latest innovations are groundbreaking patents that include cyanotriazole compounds and N,N-substituted 3-aminopyrrolidine compounds. The cyanotriazole compound, represented by a specific formula, is designed to stimulate citric acid cycle activity and improve hyperglycemia with minimal side effects, making it a potential treatment for diabetes, insulin resistance, and cardiovascular diseases. Similarly, the pyrrolidine compound, with a unique general formula, serves as a monoamines reuptake inhibitor and promises a broader therapeutic spectrum, offering substantial health benefits even with short-term use.

Career Highlights: Yohji Sakurai is affiliated with Otsuka Pharmaceutical Company, Limited, where he leverages his expertise to advance pharmaceutical research and development. His inventive spirit and dedication have resulted in numerous advancements that aim to improve patient outcomes across various health issues.

Collaborations: Throughout his career, Sakurai has collaborated with several esteemed colleagues in the field, including Nobuaki Ito and Shinichi Taira. Their joint efforts have played a crucial role in enhancing the research landscape and fostering innovation within the pharmaceutical domain.

Conclusion: Yohji Sakurai's contributions as an inventor in the pharmaceutical industry underscore the importance of innovation in developing effective health solutions. With his ongoing work and dedication, he continues to pave the way for advancements that positively impact the medical community and society at large.

Profile summary based on public USPTO records.